These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 30593831)

  • 21. NIR-induced spatiotemporally controlled gene silencing by upconversion nanoparticle-based siRNA nanocarrier.
    Chen G; Ma B; Xie R; Wang Y; Dou K; Gong S
    J Control Release; 2018 Jul; 282():148-155. PubMed ID: 29287907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioreducible poly (β-amino esters)/shRNA complex nanoparticles for efficient RNA delivery.
    Yin Q; Gao Y; Zhang Z; Zhang P; Li Y
    J Control Release; 2011 Apr; 151(1):35-44. PubMed ID: 21244853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing.
    Cardoso AL; Simões S; de Almeida LP; Pelisek J; Culmsee C; Wagner E; Pedroso de Lima MC
    J Gene Med; 2007 Mar; 9(3):170-83. PubMed ID: 17351968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Technologies for investigating the physiological barriers to efficient lipid nanoparticle-siRNA delivery.
    Shi B; Abrams M
    J Histochem Cytochem; 2013 Jun; 61(6):407-20. PubMed ID: 23504369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polysaccharide Nanoparticles for Efficient siRNA Targeting in Cancer Cells by Supramolecular pKa Shift.
    Zhang YM; Yang Y; Zhang YH; Liu Y
    Sci Rep; 2016 Jul; 6():28848. PubMed ID: 27363811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of lipid substitution on assembly and delivery of siRNA by cationic polymers.
    Aliabadi HM; Landry B; Bahadur RK; Neamnark A; Suwantong O; Uludağ H
    Macromol Biosci; 2011 May; 11(5):662-72. PubMed ID: 21322108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipid-based vectors for siRNA delivery.
    Zhang S; Zhi D; Huang L
    J Drug Target; 2012 Nov; 20(9):724-35. PubMed ID: 22994300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Engineered ionizable lipid siRNA conjugates enhance endosomal escape but induce toxicity in vivo.
    Biscans A; Ly S; McHugh N; Cooper DA; Khvorova A
    J Control Release; 2022 Sep; 349():831-843. PubMed ID: 35917865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disulfide-based poly(amido amine)s for siRNA delivery: effects of structure on siRNA complexation, cellular uptake, gene silencing and toxicity.
    Vader P; van der Aa LJ; Engbersen JF; Storm G; Schiffelers RM
    Pharm Res; 2011 May; 28(5):1013-22. PubMed ID: 21181546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell-penetrating peptide-conjugated lipid nanoparticles for siRNA delivery.
    Asai T; Tsuzuku T; Takahashi S; Okamoto A; Dewa T; Nango M; Hyodo K; Ishihara H; Kikuchi H; Oku N
    Biochem Biophys Res Commun; 2014 Feb; 444(4):599-604. PubMed ID: 24486551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation, Characterization, and In Vitro Evaluation of Lipidoid-Polymer Hybrid Nanoparticles for siRNA Delivery to the Cytosol.
    Thanki K; Zeng X; Foged C
    Methods Mol Biol; 2019; 1943():141-152. PubMed ID: 30838614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The development of an in vitro assay to screen lipid based nanoparticles for siRNA delivery.
    Zhang Y; Arrington L; Boardman D; Davis J; Xu Y; DiFelice K; Stirdivant S; Wang W; Budzik B; Bawiec J; Deng J; Beutner G; Seifried D; Stanton M; Gindy M; Leone A
    J Control Release; 2014 Jan; 174():7-14. PubMed ID: 24240015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of particle size on the in vivo potency of lipid nanoparticle formulations of siRNA.
    Chen S; Tam YYC; Lin PJC; Sung MMH; Tam YK; Cullis PR
    J Control Release; 2016 Aug; 235():236-244. PubMed ID: 27238441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carbohydrate-interactive pDNA and siRNA gene vectors based on boronic acid functionalized poly(amido amine)s.
    Piest M; Ankoné M; Engbersen JF
    J Control Release; 2013 Aug; 169(3):266-75. PubMed ID: 23428840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The development of tertiary amine cationic lipids for safe and efficient siRNA delivery.
    Lin Z; Bao M; Yu Z; Xue L; Ju C; Zhang C
    Biomater Sci; 2019 Jul; 7(7):2777-2792. PubMed ID: 31041934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced intracellular siRNA delivery using bioreducible lipid-like nanoparticles.
    Wang M; Alberti K; Varone A; Pouli D; Georgakoudi I; Xu Q
    Adv Healthc Mater; 2014 Sep; 3(9):1398-403. PubMed ID: 24574196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor-targeted pH/redox dual-sensitive unimolecular nanoparticles for efficient siRNA delivery.
    Chen G; Wang Y; Xie R; Gong S
    J Control Release; 2017 Aug; 259():105-114. PubMed ID: 28159516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimization of poly(amido amine)s as vectors for siRNA delivery.
    van der Aa LJ; Vader P; Storm G; Schiffelers RM; Engbersen JF
    J Control Release; 2011 Mar; 150(2):177-86. PubMed ID: 21130817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipidoid-polymer hybrid nanoparticles loaded with TNF siRNA suppress inflammation after intra-articular administration in a murine experimental arthritis model.
    Jansen MAA; Klausen LH; Thanki K; Lyngsø J; Skov Pedersen J; Franzyk H; Nielsen HM; van Eden W; Dong M; Broere F; Foged C; Zeng X
    Eur J Pharm Biopharm; 2019 Sep; 142():38-48. PubMed ID: 31199978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rationally Designed Polycationic Carriers for Potent Polymeric siRNA-Mediated Gene Silencing.
    Wu C; Li J; Wang W; Hammond PT
    ACS Nano; 2018 Jul; 12(7):6504-6514. PubMed ID: 29944833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.